These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 8776020)

  • 41. [Treatment of idiopathic thrombopenic purpura in adolescents by intravenous immunoglobulin].
    Rodríguez Cuartero A; González Martínez F
    An Med Interna; 1998 Dec; 15(12):675-6. PubMed ID: 9972611
    [No Abstract]   [Full Text] [Related]  

  • 42. Differences in immunoglobulin preparations and outcome of Kawasaki disease.
    Yavuz H; Ozel A
    J Pediatr; 1996 May; 128(5 Pt 1):719-20. PubMed ID: 8627453
    [No Abstract]   [Full Text] [Related]  

  • 43. Positive hepatitis serologies with treatment for Kawasaki syndrome.
    Borowitz SM
    Arch Dis Child; 1993 Jan; 68(1):151. PubMed ID: 8435007
    [No Abstract]   [Full Text] [Related]  

  • 44. Randomised trial of intravenous immunoglobulin G, intravenous anti-D, and oral prednisone in childhood acute immune thrombocytopenic purpura.
    Blanchette V; Imbach P; Andrew M; Adams M; McMillan J; Wang E; Milner R; Ali K; Barnard D; Bernstein M
    Lancet; 1994 Sep; 344(8924):703-7. PubMed ID: 7915773
    [TBL] [Abstract][Full Text] [Related]  

  • 45. ASHP therapeutic guidelines for intravenous immune globulin. ASHP Commission on Therapeutics.
    Clin Pharm; 1992 Feb; 11(2):117-36. PubMed ID: 1312920
    [No Abstract]   [Full Text] [Related]  

  • 46. [Intravenous immunoglobulins and autoimmune thrombopenic purpura].
    Godeau B; Bierling P
    Rev Med Interne; 1999; 20 Suppl 4():440s-443s. PubMed ID: 10522320
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical uses of intravenous immunoglobulin in pregnancy.
    Clark AL; Gall SA
    Am J Obstet Gynecol; 1997 Jan; 176(1 Pt 1):241-53. PubMed ID: 9024121
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The indications for intravenous immunoglobulins in pediatric practice].
    Popescu V; Bleahu D
    Pediatrie (Bucur); 1992; 41(1):37-45. PubMed ID: 1322724
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Changes in BAFF/APRIL levels in a 2-year-old girl with Kawasaki disease refractory to intravenous immunoglobulin therapy.
    Yoshida S; Sakurai Y; Takeda T; Fukuda K
    J Investig Allergol Clin Immunol; 2013; 23(1):52-3. PubMed ID: 23653975
    [No Abstract]   [Full Text] [Related]  

  • 50. Efficacy and Safety of Anti-D Immunoglobulins versus Intravenous Immunoglobulins for Immune Thrombocytopenia in Children: Systematic Review and Meta-analysis of Randomized Controlled Trials.
    Lioger B; Maillot F; Ternant D; Passot C; Paintaud G; Bejan-Angoulvant T
    J Pediatr; 2019 Jan; 204():225-233.e8. PubMed ID: 30314658
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Assessment of the efficacy of a last-generation polyvalent immunoglobulin in the treatment of idiopathic thrombocytopenic purpura.
    Pacetti P; Garau D; Caramatti C; Mangoni L; Zamboni V; Canova N; Rizzoli V
    Curr Med Res Opin; 1997; 13(9):517-27. PubMed ID: 9169254
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Intravenous immunoglobulin-related acute coronary syndrome and coronary angiography in idiopathic thrombocytopenic purpura--a case report and literature review.
    Crouch ED; Watson LE
    Angiology; 2002; 53(1):113-7. PubMed ID: 11863304
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Both patient characteristics and IVIG product-specific mechanisms may affect eosinophils in immunoglobulin-treated Kawasaki disease.
    Khan S; Doré PC; Sewell WA
    Pediatr Allergy Immunol; 2008 Mar; 19(2):186-7. PubMed ID: 18257907
    [No Abstract]   [Full Text] [Related]  

  • 54. Infliximab for intensification of primary therapy for Kawasaki disease: a phase 3 randomised, double-blind, placebo-controlled trial.
    Tremoulet AH; Jain S; Jaggi P; Jimenez-Fernandez S; Pancheri JM; Sun X; Kanegaye JT; Kovalchin JP; Printz BF; Ramilo O; Burns JC
    Lancet; 2014 May; 383(9930):1731-8. PubMed ID: 24572997
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Acute myocardial infarction during treatment with intravenous immunoglobulin for idiopathic thrombocytopenic purpura (ITP).
    Paolini R; Fabris F; Cella G
    Am J Hematol; 2000 Oct; 65(2):177-8. PubMed ID: 10996840
    [No Abstract]   [Full Text] [Related]  

  • 56. Anti-D testing in intravenous immunoglobulins: shouldn't it be considered.
    Pisani G; Wirz M; Gentili G
    Vox Sang; 1996; 71(2):132. PubMed ID: 8873429
    [No Abstract]   [Full Text] [Related]  

  • 57. [Plasma exchange therapy for Kawasaki disease refractory to intravenous immunoglobulin].
    Mori M
    Nihon Rinsho; 2008 Feb; 66(2):349-54. PubMed ID: 18260334
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Intravenous immunoglobulins: clinical experience and viral safety.
    Ballow M
    J Am Pharm Assoc (Wash); 2002; 42(3):449-58; quiz 458-9. PubMed ID: 12030632
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The response to high-dose intravenous immunoglobulin or steroids is not predictive of outcome after splenectomy in adults with autoimmune thrombocytopenic purpura.
    Ruivard M; Caulier MT; Vantelon JM; Tournilhac O; Schaeffer A; Godeau B; Bierling P
    Br J Haematol; 1999 Jun; 105(4):1130-2. PubMed ID: 10554833
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Kawasaki disease.
    Sundel RP
    Rheum Dis Clin North Am; 2015; 41(1):63-73, viii. PubMed ID: 25399940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.